Clinical Trial Update: A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update shows the SEP-380135 study in adults with schizophrenia or major depressive episode has completed. The trial scope also lists bipo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Major Depressive Disorder
• Schizophrenia

Drugs mentioned

• SEP-380135 (SEP-380135)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia, Major Depressive Disorder (MDD) | Phase 1 | Status: COMPLETED